# Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

> **NCT03194932** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 62 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Venetoclax
- **DRUG:** Cytarabine
- **DRUG:** Idarubicin
- **DRUG:** Intrathecal Triple Therapy
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT03194932
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-11
- **Primary completion:** 2020-10-27
- **Final completion:** 2022-06-22
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2023-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03194932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03194932, "Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03194932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*